No stranger to controversy.
D000818:Animals; D019313:BRCA1 Protein / Q000235:genetics* / Q000378:metabolism / Q000494:pharmacology*; D024682:BRCA2 Protein; D002986:Clinical Trials as Topic; D003593:Cytoplasm / Q000235:genetics; D004268:DNA-Binding Proteins / Q000235:genetics; D005260:Female; D006801:Humans; D051379:Mice; D009363:Neoplasm Proteins / Q000235:genetics*; D010051:Ovarian Neoplasms / Q000235:genetics / Q000628:therapy; D051135:Rad51 Recombinase; D012190:Retroviridae / Q000235:genetics; D014157:Transcription Factors / Q000235:genetics*; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
D019313:BRCA1 Protein; D024682:BRCA2 Protein; D004268:DNA-Binding Proteins; D009363:Neoplasm Proteins; D014157:Transcription Factors; D016159:Tumor Suppressor Protein p53; C495153:RAD51 protein, human; D051135:Rad51 Recombinase; C495154:Rad51 protein, mouse